The Manufacturers Life Insurance Company grew its stake in shares of Humana Inc (NYSE:HUM) by 9.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 172,384 shares of the insurance provider’s stock after acquiring an additional 15,425 shares during the period. The Manufacturers Life Insurance Company owned 0.12% of Humana worth $42,764,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of HUM. Sterling Capital Management LLC purchased a new stake in shares of Humana in the second quarter worth $253,000. Deschutes Portfolio Strategy LLC purchased a new stake in shares of Humana in the third quarter worth $221,000. Robeco Institutional Asset Management B.V. raised its position in shares of Humana by 5.1% in the third quarter. Robeco Institutional Asset Management B.V. now owns 137,119 shares of the insurance provider’s stock worth $33,403,000 after buying an additional 6,694 shares in the last quarter. Meeder Asset Management Inc. raised its position in shares of Humana by 2.3% in the third quarter. Meeder Asset Management Inc. now owns 23,101 shares of the insurance provider’s stock worth $5,628,000 after buying an additional 519 shares in the last quarter. Finally, Oakbrook Investments LLC purchased a new stake in shares of Humana in the third quarter worth $1,523,000. Institutional investors own 97.68% of the company’s stock.
In other news, SVP Brian P. Leclaire sold 1,679 shares of Humana stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $245.97, for a total transaction of $412,983.63. Following the completion of the transaction, the senior vice president now directly owns 9,888 shares in the company, valued at $2,432,151.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Jody L. Bilney sold 7,054 shares of Humana stock in a transaction that occurred on Monday, December 18th. The shares were sold at an average price of $247.89, for a total transaction of $1,748,616.06. Following the transaction, the senior vice president now owns 11,704 shares of the company’s stock, valued at $2,901,304.56. The disclosure for this sale can be found here. Insiders have sold 10,115 shares of company stock valued at $2,501,627 over the last quarter. Company insiders own 0.80% of the company’s stock.
A number of brokerages recently issued reports on HUM. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $294.00 price objective on the stock in a research report on Monday, February 12th. JPMorgan Chase & Co. raised their price target on Humana from $253.00 to $271.00 and gave the company a “neutral” rating in a research report on Monday, February 12th. Deutsche Bank raised their price target on Humana from $259.00 to $270.00 and gave the company a “hold” rating in a research report on Friday, February 9th. Oppenheimer raised their price target on Humana from $275.00 to $305.00 and gave the company an “outperform” rating in a research report on Thursday, February 8th. Finally, Leerink Swann raised their price objective on Humana from $280.00 to $300.00 and gave the company an “outperform” rating in a research note on Thursday, February 8th. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $270.47.
Humana Inc (HUM) opened at $269.00 on Tuesday. Humana Inc has a 1-year low of $203.36 and a 1-year high of $293.35. The stock has a market cap of $37,037.08, a P/E ratio of 16.13, a PEG ratio of 1.45 and a beta of 0.93. The company has a current ratio of 1.85, a quick ratio of 1.61 and a debt-to-equity ratio of 0.48.
Humana (NYSE:HUM) last released its earnings results on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.00 by $0.06. Humana had a net margin of 4.55% and a return on equity of 16.13%. The firm had revenue of $13.19 billion during the quarter, compared to analyst estimates of $13.14 billion. During the same period last year, the business earned $2.34 earnings per share. The business’s revenue was up 2.4% on a year-over-year basis. sell-side analysts predict that Humana Inc will post 13.86 EPS for the current fiscal year.
Humana declared that its Board of Directors has authorized a share repurchase program on Thursday, December 14th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the insurance provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s leadership believes its shares are undervalued.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.74%. This is a positive change from Humana’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Wednesday, March 28th. Humana’s dividend payout ratio (DPR) is presently 9.59%.
TRADEMARK VIOLATION WARNING: “The Manufacturers Life Insurance Company Buys 15,425 Shares of Humana Inc (HUM)” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/20/the-manufacturers-life-insurance-company-buys-15425-shares-of-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.